Farnesoid X receptor (FXR) as a potential therapeutic target in nonalcoholic fatty liver disease and associated syndromes

Nonalcoholic fatty liver disease (NAFLD) is a group of obesity-associated pathological changes characterized by abnormal accumulation of lipids in cells of the liver parenchyma. NAFLD and associated conditions, namely insulin resistance and type II diabetes mellitus (DM2), as well as the possible ri...

Descrición completa

Detalles Bibliográficos

Principais autores:	Apollinariya V. Bogolyubova, Alexander Y. Mayorov, Ekaterina E. Mishina, Anton M. Schwartz, Pavel V. Belousov
Formato:	Artigo
Idioma:	Inglês
Publicado:	Endocrinology Research Centre 2017-12-01
Series:	Сахарный диабет
Assuntos:	nonalcoholic fatty liver disease nonalcoholic steatohepatitis farnesoid x
Acceso en liña:	https://www.dia-endojournals.ru/jour/article/view/9374
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!